• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The cost of influenza-associated hospitalizations and outpatient visits in Kenya

tetano

Editor, Senior Moderator
BMC Public Health. 2019 May 10;19(Suppl 3):471. doi: 10.1186/s12889-019-6773-6.
The cost of influenza-associated hospitalizations and outpatient visits in Kenya.


Emukule GO[SUP]1[/SUP], Ndegwa LK[SUP]2[/SUP], Washington ML[SUP]3[/SUP], Paget JW[SUP]4,[/SUP][SUP]5[/SUP], Duque J[SUP]6[/SUP], Chaves SS[SUP]2,[/SUP][SUP]6[/SUP], Otieno NA[SUP]7[/SUP], Wamburu K[SUP]7[/SUP], Ndigirigi IW[SUP]8[/SUP], Muthoka PM[SUP]8[/SUP], van der Velden K[SUP]5[/SUP], Mott JA[SUP]2,[/SUP][SUP]6,[/SUP][SUP]9[/SUP].

Author information




Abstract

BACKGROUND:

We estimated the cost-per-episode and the annual economic burden associated with influenza in Kenya.
METHODS:

From July 2013-August 2014, we recruited patients with severe acute respiratory illness (SARI) or influenza-like illness (ILI) associated with laboratory-confirmed influenza from 5 health facilities. A structured questionnaire was used to collect direct costs (medications, laboratory investigations, hospital bed fees, hospital management costs, transportation) and indirect costs (productivity losses) associated with an episode of influenza. We used published incidence of laboratory-confirmed influenza associated with SARI and ILI, and the national population census data from 2014, to estimate the annual national number of influenza-associated hospitalizations and outpatient visits and calculated the annual economic burden by multiplying cases by the mean cost.
RESULTS:

We enrolled 275 patients (105 inpatients and 170 outpatients). The mean cost-per-episode of influenza was US$117.86 (standard deviation [SD], 88.04) among inpatients; US$114.25 (SD, 90.03) for children < 5 years, and US$137.45 (SD, 76.24) for persons aged ≥5 years. Among outpatients, the mean cost-per-episode of influenza was US$19.82 (SD, 27.29); US$21.49 (SD, 31.42) for children < 5 years, and US$16.79 (SD, 17.30) for persons aged ≥5 years. National annual influenza-associated cost estimates ranged from US$2.96-5.37 million for inpatients and US$5.96-26.35 million for outpatients.
CONCLUSIONS:

Our findings highlight influenza as causing substantial economic burden in Kenya. Further studies may be warranted to assess the potential benefit of targeted influenza vaccination strategies.



KEYWORDS:

Cost; Cost-per-episode; Economic burden; Hospitalization; Influenza; Kenya; Outpatient


PMID:32326937DOI:10.1186/s12889-019-6773-6
 
Back
Top Bottom